POSSIBILITIES OF MIFEPRISTONE USE AFTER SURGICAL THERAPY OF UTERINE MYOMA

The effectiveness  of mifepristone (Gynestril) use in patients after surgical therapy of uterine myoma (laparoscopic myomectomy, embolization of uterine arteries, hysteroresectoscopy) was studied. It was shown that use of mifepristone at a dosage 50 mg per day in an intermittent regime for 3 months...

Full description

Bibliographic Details
Main Authors: S. V. Apresyan, V. I. Dimitrova, O. A. Slyusareva
Format: Article
Language:Russian
Published: Remedium Group LLC 2016-12-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/1448
_version_ 1797841402159169536
author S. V. Apresyan
V. I. Dimitrova
O. A. Slyusareva
author_facet S. V. Apresyan
V. I. Dimitrova
O. A. Slyusareva
author_sort S. V. Apresyan
collection DOAJ
description The effectiveness  of mifepristone (Gynestril) use in patients after surgical therapy of uterine myoma (laparoscopic myomectomy, embolization of uterine arteries, hysteroresectoscopy) was studied. It was shown that use of mifepristone at a dosage 50 mg per day in an intermittent regime for 3 months after surgical therapy main myoma of a uterus led to statistically significant reduction of the uterine volume in 96% of women (p < 0.05) and reduction of recurrence of uterine myoma for a year after the drug withdrawal.
first_indexed 2024-04-09T16:30:16Z
format Article
id doaj.art-f79c0b1850444b1693195f455ad71ac6
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:30:16Z
publishDate 2016-12-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-f79c0b1850444b1693195f455ad71ac62023-04-23T06:57:07ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902016-12-0101214214510.21518/2079-701X-2016-12-142-1451444POSSIBILITIES OF MIFEPRISTONE USE AFTER SURGICAL THERAPY OF UTERINE MYOMAS. V. Apresyan0V. I. Dimitrova1O. A. Slyusareva2Inozemtsev Municipal Clinical Hospital, MoscowInozemtsev Municipal Clinical Hospital, MoscowInozemtsev Municipal Clinical Hospital, MoscowThe effectiveness  of mifepristone (Gynestril) use in patients after surgical therapy of uterine myoma (laparoscopic myomectomy, embolization of uterine arteries, hysteroresectoscopy) was studied. It was shown that use of mifepristone at a dosage 50 mg per day in an intermittent regime for 3 months after surgical therapy main myoma of a uterus led to statistically significant reduction of the uterine volume in 96% of women (p < 0.05) and reduction of recurrence of uterine myoma for a year after the drug withdrawal.https://www.med-sovet.pro/jour/article/view/1448uterine myomamifepristoneembolization of uterine arterieslaparoscopic myomectomymain myoma of a uterus
spellingShingle S. V. Apresyan
V. I. Dimitrova
O. A. Slyusareva
POSSIBILITIES OF MIFEPRISTONE USE AFTER SURGICAL THERAPY OF UTERINE MYOMA
Медицинский совет
uterine myoma
mifepristone
embolization of uterine arteries
laparoscopic myomectomy
main myoma of a uterus
title POSSIBILITIES OF MIFEPRISTONE USE AFTER SURGICAL THERAPY OF UTERINE MYOMA
title_full POSSIBILITIES OF MIFEPRISTONE USE AFTER SURGICAL THERAPY OF UTERINE MYOMA
title_fullStr POSSIBILITIES OF MIFEPRISTONE USE AFTER SURGICAL THERAPY OF UTERINE MYOMA
title_full_unstemmed POSSIBILITIES OF MIFEPRISTONE USE AFTER SURGICAL THERAPY OF UTERINE MYOMA
title_short POSSIBILITIES OF MIFEPRISTONE USE AFTER SURGICAL THERAPY OF UTERINE MYOMA
title_sort possibilities of mifepristone use after surgical therapy of uterine myoma
topic uterine myoma
mifepristone
embolization of uterine arteries
laparoscopic myomectomy
main myoma of a uterus
url https://www.med-sovet.pro/jour/article/view/1448
work_keys_str_mv AT svapresyan possibilitiesofmifepristoneuseaftersurgicaltherapyofuterinemyoma
AT vidimitrova possibilitiesofmifepristoneuseaftersurgicaltherapyofuterinemyoma
AT oaslyusareva possibilitiesofmifepristoneuseaftersurgicaltherapyofuterinemyoma